Drugs / disodium cromoglycate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00777348 | Nov 2007 → Oct 2008 | asthma | MEDA Pharma GmbH & Co. KG | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02664051 | Aug 2013 → Dec 2016 | dyspepsia | Universitaire Ziekenhuizen KU Leuven | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02177370 Comparator | Feb 1990 → Oct 1996 | asthma | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | disodium cromoglycate | “compare the effect of fenoterol metered dose inhaler with disodium cromoglycate (DSCG) metered dose inhaler on the lymphocyte β2-receptor population” NCT02177370 ↗2“Drug: disodium cromoglycate 100mg 4x2 daily Other Names: • Nalcrom” NCT02664051 ↗ “fixed combination of disodium cromoglycate (DSCG) plus reproterol” NCT00777348 ↗ |
| Known as | DSCG | “compare the effect of fenoterol metered dose inhaler with disodium cromoglycate (DSCG) metered dose inhaler on the lymphocyte β2-receptor population” NCT02177370 ↗1“fixed combination of disodium cromoglycate (DSCG) plus reproterol” NCT00777348 ↗ |
| Route | Inhaled | “DSCG metered dose inhaler” NCT02177370 ↗ |